Markus Schwaiger
Papers
1
Total Citations
21
H-Index
1
About
Markus Schwaiger is a pioneering figure in nuclear medicine and molecular imaging, with a career dedicated to advancing theranostic approaches for cancer management. His research focuses on the development and clinical translation of targeted imaging agents, particularly for prostate cancer, where he has made seminal contributions to the field of PSMA (prostate-specific membrane antigen) theranostics. Schwaiger’s landmark work on PSMA-based PET imaging and subsequent radioguided surgery has revolutionized the detection and treatment of recurrent prostate cancer, enabling precise localization of metastatic lesions and guiding surgical interventions. His 2016 study on this topic, which has garnered over 21 citations, exemplifies his impact in bridging diagnostic imaging with therapeutic strategies. Beyond this, Schwaiger has been instrumental in validating novel radiotracers for assessing tumor biology and treatment response, earning him recognition as a leader in personalized oncology. With a career spanning decades, his contributions have not only advanced clinical practice but also inspired a generation of researchers to explore the synergy between imaging and targeted therapy.
Research Focus
Key Achievements
Top Papers
- 1